Biotech stock doubles in single day after treatment for a rare lung disease has successful trial

Shares of Insmed more than doubled on Tuesday after the drug maker said a new inhaled antibiotic showed promise for treating a rare lung disease, and it announced plans to sell $250 million shares to the public. The stock jumped to $26.99 on Tuesday from just over...

Crisis Is Over at Texas Plant, but Chemical Safety Flaws Remain

By CLIFFORD KRAUSS, HIROKO TABUCHI and HENRY FOUNTAIN September 5, 2017 CROSBY, Tex. — Residents have returned to their homes here in the shadow of the Arkema chemical plant now that the fires at the plant are out and the immediate...